Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Cardiology
Published in: Pediatric Cardiology 4/2006

01-08-2006

Superior Vena Cava and Innominate Vein Dimensions in Growing Children

An Aid for Interventional Devices and Transvenous Leads

Authors: Sanjeev Sanjeev, Peter P. Karpawich

Published in: Pediatric Cardiology | Issue 4/2006

Login to get access

Abstract

Transvenous (TV) pacing and defibrillation leads are frequently implanted in children as part of treatment for various congenital and acquired rhythm abnormalities. However, the lead–vascular endothelial interaction is not a benign process and is associated with a risk of progressive venous obstruction. Often, this obstruction requires surgical or interventional relief. The risk of obstruction is related to venous diameters at implant and lead size. Since venous diameters are largely unknown at different ages, the purpose of this study was to correlate innominate vein (INN) and superior vena cava (SVC) diameters with body dimensions in growing children.
Literature
1.
Antonelli D, Turgeman Y, Kaveh Z, Artoul S, Rosenfeld T (1989) Short-term thrombosis after transvenous permanent pacemaker insertion. Pacing Clin Electrophysiol 12:280–282PubMedCrossRef
2.
Antretter H, Hangler H, Colvin J, Laufer G (2001) Inferior vena caval loop of an endocardial pacing lead did not solve the growth problem in a child. Pacing Clin Electrophysiol 24:1706–1709PubMedCrossRef
3.
Chardack WM, Gage AA, Federico AJ, Schimert G, Greatbatch W (1966) The long-term treatment of heart block. Prog Cardiovasc Dis 9:105–135PubMed
4.
Epstein ML, Goldberg SJ, Allen HD, Konecke L, Wood J (1975) Great vessel, cardiac chamber, and wall growth patterns in normal children. Circulation 51:1124–1129PubMed
5.
Figa FH, McCrindle BW, Bigras JL, Hamilton RM, Gow RM (1997) Risk factors for venous obstruction in children with transvenous pacing leads. Pacing Clin Electrophysiol 20:1902–1909PubMedCrossRef
6.
Gheissarj A, Hordof AJ, Spotnitz HM (1991) Transvenous pacemakers in children: relation of lead length to anticipated growth. Ann Thorac Surg 52:118–121CrossRef
7.
Gillette PC, Zeigler V, Bradham GB, Kinsella P (1988) Pediatric transvenous pacing: a concern for venous thrombosis? Pacing Clin Electrophysiol 11:1935–1939PubMedCrossRef
8.
Goudevenos JA, Reid PG, Adams PC, Holden MP, Williams DO (1989) Pacemaker-induced superior vena cava syndrome: report of four cases and review of the literature. Pacing Clin Electrophysiol 12:1890–1895PubMedCrossRef
9.
Hansky B, Blanz U, Peuster M, et al. (2005) Endocardial pacing after Fontan-type procedures. Pacing Clin Electrophysiol 28:140–148PubMedCrossRef
10.
Hayes DL, Holmes DR Jr, Maloney JD, et al. (1983) Permanent endocardial pacing in pediatric patients. J Thorac Cardiovasc Surg 85:618–624PubMed
11.
Lau YR, Gillette PC, Buckles DS, Zeigler VL (1993) Actuarial survival of transvenous pacing leads in a pediatric population. Pacing Clin Electrophysiol 16:1363–1367PubMedCrossRef
12.
Mazzetti H, Dussaut A, Tentori C, Dussaut E, Lazzari JO (1993) Superior vena cava occlusion and/or syndrome related to pacemaker leads. Am Heart J 125:831–837PubMedCrossRef
13.
Molina JE, Dunnigan AC, Crosson JE (1995) Implantation of transvenous pacemakers in infants and small children. Ann Thorac Surg 59:689–694PubMedCrossRef
14.
Nidorf SM, Picard MH, Triulzi MO, et al. (1992) New perspectives in the assessment of cardiac chamber dimensions during development and adulthood. J Am Coll Cardiol 19:983–988PubMedCrossRef
15.
O’Sullivan JJ, Jameson S, Gold RG, Wren C (1993) Endocardial pacemakers in children: lead length and allowance for growth. Pacing Clin Electrophysiol 16:267–271PubMedCrossRef
16.
Palatianos GM, Dewanjee MK, Panoutsopoulos G, et al. (1994) Comparative thrombogenicity of pacemaker leads. Pacing Clin Electrophysiol 17:14l–145CrossRef
17.
Pearce WH, Slaughter MS, LeMaire S, et al. (1993) Aortic diameter as a function of age, gender, and body surface area. Surgery 114:691–697PubMed
18.
Shah MJ, Nehgme R, Carboni M, Murphy JD (2004) Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the Fontan procedure. Pacing Clin Electrophysiol 27:949–954PubMedCrossRef
19.
Sheil ML, Jenkins O, Sholler GF (1995) Echocardiographic assessment of aortic root dimensions in normal children based on measurement of a new ratio of aortic size independent of growth. Am J Cardiol 75:711–715PubMedCrossRef
20.
Spittell PC, Hayes DL (1992) Venous complications after insertion of a transvenous pacemaker. Mayo Clinic Proc 67:258–265
21.
Ward DE, Jones S, Shinebourne EA (1987) Long-term transvenous pacing in children weighing ten kilograms or less. Int J Cardiol 15:112–115PubMedCrossRef
Metadata
Title
Superior Vena Cava and Innominate Vein Dimensions in Growing Children
An Aid for Interventional Devices and Transvenous Leads
Authors
Sanjeev Sanjeev
Peter P. Karpawich
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 4/2006
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-006-1133-6

Other articles of this Issue 4/2006

Pediatric Cardiology 4/2006 Go to the issue

OriginalPaper

Radiofrequency Catheter Ablation of Supraventricular Tachycardia in Children and Adolescents

OriginalPaper

Right Ventricular and Pulmonary Function in Sickle Cell Disease Patients with Pulmonary Hypertension

OriginalPaper

Evidence for an Association Between Type 1 Diabetes and Premature Carotid Atherosclerosis in Childhood

IMAGES IN PEDIATRIC CARDIOLOGY

Unusually Redundant Chiari Network

OriginalPaper

From Other Journals

OriginalPaper

Redirection of Hepatic Drainage for Treatment of Pulmonary Arteriovenous Malformations Following the Fontan Procedure

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits